Scholten T, Fritsch W P, Müller J E, Hengels K J
Dtsch Med Wochenschr. 1979 Dec 28;104(52):1849-53. doi: 10.1055/s-0028-1129204.
Inhibition of acid secretion was investigated in 5 patients with Zollinger-Ellison syndrome and 12 patients with duodenal ulcer after administration of 200 mg cimetidine alone and combined with 50 mg methanthelinebromide. A preinvestigation of 5 patients had not shown any significant decrease of acid secretion after 50 mg methanthelinebromide alone. Compared with a single dose of 200 mg cimetidine, combined drugs' use (200 mg cimetidine and 50 mg methanthelinebromide) led to significant increase of inhibition of secretion both as regards degree and duration. In 6 patients with duodenal ulcer basal secretion of more than 2.0 mmol H+/h 200 mg cimetidine led to inhibition of secretion by 91.4% over 120 min compared to 96.4% over 225 min after combined administration. Similar results were obtained in 6 patients with a basal secretion of less than 2.0 mmol H+/h.
对5例卓-艾综合征患者和12例十二指肠溃疡患者,在单独给予200毫克西咪替丁以及联合给予200毫克西咪替丁和50毫克溴甲贝那替嗪后,研究了胃酸分泌的抑制情况。对5例患者进行的前期研究显示,单独给予50毫克溴甲贝那替嗪后,胃酸分泌未出现任何显著下降。与单剂量200毫克西咪替丁相比,联合用药(200毫克西咪替丁和50毫克溴甲贝那替嗪)在抑制程度和持续时间方面均导致胃酸分泌抑制显著增加。在6例基础分泌超过2.0毫摩尔H⁺/小时的十二指肠溃疡患者中,200毫克西咪替丁在120分钟内使分泌抑制91.4%,而联合给药后在225分钟内抑制96.4%。在6例基础分泌低于2.0毫摩尔H⁺/小时的患者中也获得了类似结果。